Ticker Details
Royalty Pharma plc
IPO Date:	June 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$24.16B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 1.17%
Avg Daily Range (30 D):	$0.47 | 0.94%
Avg Daily Range (90 D):	$0.44 | 0.94%

Institutional Daily Volume
Avg Daily Volume:	2.13M
Avg Daily Volume (30 D):	2.47M
Avg Daily Volume (90 D):	2.74M

Trade Size
Avg Trade Size (Sh.):	90
Avg Trade Size (Sh.) (30 D):	68
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	9,886
Avg Institutional Trade:	$4.81M
Avg Institutional Trade (30 D):	$5.85M
Avg Institutional Trade (90 D):	$5.25M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	6

Market Closing Trades
Avg Closing Trade:	$14.75M
Avg Closing Trade (30 D):	$25.8M
Avg Closing Trade (90 D):	$25.91M
Avg Closing Volume:	403.86K

News

Apr 21, 2026 @ 5:00 PM Royalty Pharma Launches Global Translational Prize... Source: Na

Apr 17, 2026 @ 12:30 PM Royalty Pharma Declares Second Quarter 2026 Divide... Source: Na

Apr 1, 2026 @ 10:00 AM Zymeworks Appoints Kristin Stafford as Chief Finan... Source: Na

Mar 5, 2026 @ 2:00 PM Vera Therapeutics Appoints Christopher Hite to Boa... Source: Not Specified

Mar 2, 2026 @ 12:00 PM Royalty Pharma Appoints Kenneth Sun as Senior Vice... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$1.91	$.67	$.5
Diluted EPS	$1.91	$.67	$.5
Revenue	$2.44B	$630.58M	$621.99M
Gross Profit
Net Income / Loss	$1.36B	$468.26M	$355.91M
Operating Income / Loss	$1.59B	$563.04M	$388.38M
Cost of Revenue
Net Cash Flow	$-501.33M	$-32.3M	$-320.25M
PE Ratio

Splits
Oct 15, 2010	1:4